George Zhong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
George Zhong has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Alpha Mang Sze Tung
Department of Anaesthesia, Auburn Hospital, Sydney, NSW, Australia; School of Medicine, University of Notre Dame, Sydney, NSW, Australia
3 shared publications - Bun Chan
Nagasaki University Bunkyo 1-14
3 shared publications Leo Radom
School of Chemistry and Center of Excellence for Free Radical Chemistry and Biotechnology, University of Sydney, Sydney NSW 2006, Australia
3 shared publications- Simon John Geoffrey Lewis
Parkinson’s Disease Research Clinic, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia
3 shared publications Xiabing Xu
School of Electrical and Computer Engineering, University of Sydney, Sydney, NSW, Australia
3 shared publications- Sharon Linda Naismith
University of Sydney
2 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by Springer Nature in Research Square
Optimising propofol induction in elderly patients by constraining peak plasma concentration or infusion rate during Eleveld target-controlled infusions: an in silico simulation study
Effect-site targeting with the Eleveld propofol pharmacokinetic–pharmacodynamic model often delivers a large initial propofol bolus because the model uses a relatively slow plasma-to-effect-site equilibration rate constant. This produces a marked plasma concentration overshoot, which may be undesirable in elderly or frail patients with limited haemodynamic reserve. Strategies to mitigate this include gradual up-titration of the effect-site target, use of plasma targeting mode, or limiting the maximum infusion rate, but these invariably delay achievement of the effect-site target. To examine the trade-off between induction speed and plasma overshoot, we performed an in silico simulation of an 80-year-old, 70 kg, 170 cm male receiving propofol target-controlled infusion with the Eleveld model (including opioid as a covariate). We compared standard effect-site targeting with two augmentation strategies: limiting the peak plasma concentration or limiting the maximum infusion rate. We analysed time to effect-site target, peak plasma concentration, and cumulative propofol dose over the first 15 min. Limiting either the maximum plasma concentration or the infusion rate significantly reduced plasma overshoot with minimal delay in achieving the effect-site target. Standard effect-site targeting achieved an effect-site target of 3.0 µg·mL⁻¹ in 250 s, with a peak plasma concentration of 14.1 µg·mL⁻¹. Delaying the time to effect-site target by 68 s reduced the peak plasma concentration by 52% (to 6.7 µg·mL⁻¹) with the peak plasma-limiting strategy and by 32% (to 9.6 µg·mL⁻¹) with infusion-rate limitation. All strategies required similar propofol doses at 15 min. Clinical studies are required to determine whether this pharmacokinetic trade-off translates into improved haemodynamic or electroencephalographic outcomes in elderly patients.
- 20 October 2026
- Published by Springer Nature in Research Square
Open AccessOptimising propofol induction in elderly patients by constraining peak plasma concentration or infusion rate during Eleveld target-controlled infusions: an in silico simulation study
Effect-site targeting with the Eleveld propofol pharmacokinetic–pharmacodynamic model often delivers a large initial propofol bolus because the model uses a relatively slow plasma-to-effect-site equilibration rate constant. This produces a marked plasma concentration overshoot, which may be undesirable in elderly or frail patients with limited haemodynamic reserve. Strategies to mitigate this include gradual up-titration of the effect-site target, use of plasma targeting mode, or limiting the maximum infusion rate, but these invariably delay achievement of the effect-site target. To examine the trade-off between induction speed and plasma overshoot, we performed an in silico simulation of an 80-year-old, 70 kg, 170 cm male receiving propofol target-controlled infusion with the Eleveld model (including opioid as a covariate). We compared standard effect-site targeting with two augmentation strategies: limiting the peak plasma concentration or limiting the maximum infusion rate. We analysed time to effect-site target, peak plasma concentration, and cumulative propofol dose over the first 15 min. Limiting either the maximum plasma concentration or the infusion rate significantly reduced plasma overshoot with minimal delay in achieving the effect-site target. Standard effect-site targeting achieved an effect-site target of 3.0 µg·mL⁻¹ in 250 s, with a peak plasma concentration of 14.1 µg·mL⁻¹. Delaying the time to effect-site target by 68 s reduced the peak plasma concentration by 52% (to 6.7 µg·mL⁻¹) with the peak plasma-limiting strategy and by 32% (to 9.6 µg·mL⁻¹) with infusion-rate limitation. All strategies required similar propofol doses at 15 min. Clinical studies are required to determine whether this pharmacokinetic trade-off translates into improved haemodynamic or electroencephalographic outcomes in elderly patients.
- 5 January 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 136 (3) , 1024-1025
Impact of genetic variations on the pharmacokinetics, dose requirements, and clinical effects of propofol: a modelling study. Comment on Br J Anaesth 2025; 135: 594–607
- 5 January 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 136 (3) , 1024-1025
Impact of genetic variations on the pharmacokinetics, dose requirements, and clinical effects of propofol: a modelling study. Comment on Br J Anaesth 2025; 135: 594–607
- 29 January 2025
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 134 (4) , 1253-1255
Simple model for predicting the awakening propofol plasma concentration during target-controlled infusion with the Marsh model
- 29 January 2025
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 134 (4) , 1253-1255
Simple model for predicting the awakening propofol plasma concentration during target-controlled infusion with the Marsh model
- 23 September 2024
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 53 (2) , 139-141
Mimicking the Eleveld propofol target-controlled infusion model using the Marsh model with weight adjustment in a super-obese patient
- 23 September 2024
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 53 (2) , 139-141
Mimicking the Eleveld propofol target-controlled infusion model using the Marsh model with weight adjustment in a super-obese patient
- 11 February 2024
- Published by Springer Nature in Journal of Anesthesia
- Vol. 38 (2) , 275-278
General purpose propofol target-controlled infusion using the marsh model with adjusted weight input
We report a simple method for adjusting the weight input of the Marsh target-controlled infusion (TCI) model such that the resulting infusion regime closely mimics the behaviour of the Eleveld model, thereby making the Marsh model more precise for patients at the extremes of age and body mass index. To assess the performance of our method, we simulated 2768 subjects with diverse combinations of age, weight, height and sex undergoing a hypothetical four-hour propofol TCI using both the Marsh model with our weight adjustment and the Eleveld model. The weight adjusted Marsh model produced infusion regimes and corresponding effect site concentrations closely mimicking that of the Eleveld model at all time points, with median and maximum absolute performance errors less than 8.1% and 20.3%, respectively, across the entire cohort. Our weight adjustment method is a simple and robust way of improving the precision of the Marsh model in patients at extremes of age and body mass index, until general purpose TCI models for propofol, such as the Eleveld model, become more widely available in commercial infusion pumps.
- 11 February 2024
- Published by Springer Nature in Journal of Anesthesia
- Vol. 38 (2) , 275-278
General purpose propofol target-controlled infusion using the marsh model with adjusted weight input
We report a simple method for adjusting the weight input of the Marsh target-controlled infusion (TCI) model such that the resulting infusion regime closely mimics the behaviour of the Eleveld model, thereby making the Marsh model more precise for patients at the extremes of age and body mass index. To assess the performance of our method, we simulated 2768 subjects with diverse combinations of age, weight, height and sex undergoing a hypothetical four-hour propofol TCI using both the Marsh model with our weight adjustment and the Eleveld model. The weight adjusted Marsh model produced infusion regimes and corresponding effect site concentrations closely mimicking that of the Eleveld model at all time points, with median and maximum absolute performance errors less than 8.1% and 20.3%, respectively, across the entire cohort. Our weight adjustment method is a simple and robust way of improving the precision of the Marsh model in patients at extremes of age and body mass index, until general purpose TCI models for propofol, such as the Eleveld model, become more widely available in commercial infusion pumps.
- Open Access
- 19 January 2024
- Published by Springer Nature in Research Square
General purpose propofol target-controlled infusion using the Marsh model with adjusted weight input
We report a simple method for adjusting the weight input of the Marsh target-controlled infusion (TCI) model such that the resulting infusion regime closely mimics the behavior of the Eleveld model, thereby making the Marsh model more precise for patients at the extremes of age and body mass index. To assess the performance of our method, we simulated 2,768 subjects with diverse combinations of age, weight, height and sex undergoing a hypothetical four-hour propofol TCI using both the Marsh model with our weight adjustment and the Eleveld model. The weight adjusted Marsh model produced infusion regimes and corresponding effect site concentrations closely mimicking that of the Eleveld model at all time points, with median and maximum absolute performance errors less than 8.1% and 20.3%, respectively, across the entire cohort. Our weight adjustment method is a simple and robust way of improving the precision of the Marsh model in patients at extremes of age and body mass index, until general purpose TCI models for propofol, such as the Eleveld model, become more widely available in commercial infusion pumps.
- 19 January 2024
- Published by Springer Nature in Research Square
Open AccessGeneral purpose propofol target-controlled infusion using the Marsh model with adjusted weight input
We report a simple method for adjusting the weight input of the Marsh target-controlled infusion (TCI) model such that the resulting infusion regime closely mimics the behavior of the Eleveld model, thereby making the Marsh model more precise for patients at the extremes of age and body mass index. To assess the performance of our method, we simulated 2,768 subjects with diverse combinations of age, weight, height and sex undergoing a hypothetical four-hour propofol TCI using both the Marsh model with our weight adjustment and the Eleveld model. The weight adjusted Marsh model produced infusion regimes and corresponding effect site concentrations closely mimicking that of the Eleveld model at all time points, with median and maximum absolute performance errors less than 8.1% and 20.3%, respectively, across the entire cohort. Our weight adjustment method is a simple and robust way of improving the precision of the Marsh model in patients at extremes of age and body mass index, until general purpose TCI models for propofol, such as the Eleveld model, become more widely available in commercial infusion pumps.
- 13 December 2023
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 133 (6) , 1498-1500
Audit of carbon dioxide absorbent replacement triggers and potential impact on wastage
- 13 December 2023
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 133 (6) , 1498-1500
Audit of carbon dioxide absorbent replacement triggers and potential impact on wastage
- Open Access
- 24 November 2023
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 52 (2) , 91-104
Exploring anaesthetists’ views on the carbon footprint of anaesthesia and identifying opportunities and challenges for reducing its impact on the environment
A shift in practice by anaesthetists away from anaesthetic gases with high global warming potential towards lower emission techniques (e.g. total intravenous anaesthesia) could result in significant carbon savings for the health system. The purpose of this qualitative interview study was to understand anaesthetists’ perspectives on the carbon footprint of anaesthesia, and views on shifting practice towards more environmentally sustainable options. Anaesthetists were recruited from four hospitals in Western Sydney, Australia. Data were organised according to the capability–opportunity–motivation model of behaviour change. Twenty-eight anaesthetists were interviewed (July−September 2021). Participants’ age ranged from 29 to 62 years (mean 43 years), 39% were female, and half had completed their anaesthesia training between 2010 and 2019. Challenges to the wider use of greener anaesthetic agents were identified across all components of the capability–opportunity–motivation model: capability (gaps in clinician skills and experience, uncertainty regarding research evidence); opportunity (norms, time, and resource pressures); and motivation (beliefs, habits, responsibility and guilt). Suggestions for encouraging a shift to more environmentally friendly anaesthesia included access to education and training, implementing guidelines and audit/feedback models, environmental restructuring, improving resource availability, reducing low value care, and building the research evidence base on the safety of alternative agents and their impacts on patient outcomes. We identified opportunities and challenges to reducing the carbon footprint of anaesthesia in Australian hospitals by way of system-level and individual behavioural change. Our findings will be used to inform the development of communication and behavioural interventions aiming to mitigate carbon emissions of healthcare.
- 24 November 2023
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 52 (2) , 91-104
Open AccessExploring anaesthetists’ views on the carbon footprint of anaesthesia and identifying opportunities and challenges for reducing its impact on the environment
A shift in practice by anaesthetists away from anaesthetic gases with high global warming potential towards lower emission techniques (e.g. total intravenous anaesthesia) could result in significant carbon savings for the health system. The purpose of this qualitative interview study was to understand anaesthetists’ perspectives on the carbon footprint of anaesthesia, and views on shifting practice towards more environmentally sustainable options. Anaesthetists were recruited from four hospitals in Western Sydney, Australia. Data were organised according to the capability–opportunity–motivation model of behaviour change. Twenty-eight anaesthetists were interviewed (July−September 2021). Participants’ age ranged from 29 to 62 years (mean 43 years), 39% were female, and half had completed their anaesthesia training between 2010 and 2019. Challenges to the wider use of greener anaesthetic agents were identified across all components of the capability–opportunity–motivation model: capability (gaps in clinician skills and experience, uncertainty regarding research evidence); opportunity (norms, time, and resource pressures); and motivation (beliefs, habits, responsibility and guilt). Suggestions for encouraging a shift to more environmentally friendly anaesthesia included access to education and training, implementing guidelines and audit/feedback models, environmental restructuring, improving resource availability, reducing low value care, and building the research evidence base on the safety of alternative agents and their impacts on patient outcomes. We identified opportunities and challenges to reducing the carbon footprint of anaesthesia in Australian hospitals by way of system-level and individual behavioural change. Our findings will be used to inform the development of communication and behavioural interventions aiming to mitigate carbon emissions of healthcare.
- 11 January 2023
- Published by Wiley in Anaesthesia
- Vol. 78 (5) , 653
Environmental impact of high‐flow nasal oxygenation
- 11 January 2023
- Published by Wiley in Anaesthesia
- Vol. 78 (5) , 653
Environmental impact of high‐flow nasal oxygenation
- 10 October 2022
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 51 (1) , 43-50
What airway management information do anaesthetic charts prompt for? An audit of charts from 132 hospitals across Australia and New Zealand
Anaesthetists can make safer airway plans if they know which airway techniques worked previously and which ones did not. Anaesthetic charts do not always capture this information, however, and guidelines from the Australian and New Zealand College of Anaesthetists do not specify what details on airway management they should include. To assess how anaesthetic charts support airway documentation, we audited the airway management section of blank charts from 132 hospitals accredited for training by the Australian and New Zealand College of Anaesthetists. We evaluated charts for the presence of 17 clinically important data fields describing tracheal intubation, supraglottic airway use and bag-mask ventilation. Our audit revealed that data fields on anaesthetic charts focus more on tracheal intubation than bag-mask ventilation or supraglottic airway use. Nearly all charts (99%) had prompts for intubation and most had prompts for both operator technique and patient outcome. For supraglottic airway use, 95% of charts had at least one data field, but few had prompts for difficulty or outcome. For bag-mask ventilation, 58% of charts had a data field for difficulty but most of these were subjective; few (1.5%) included any outcome measures. Data fields describing bag-mask ventilation and supraglottic airway use were also inconsistent. In summary, data fields on Australian and New Zealand anaesthetic charts focus on tracheal intubation with consistent prompts for both operator method and outcome. The inclusion of fields for outcome and difficulty of bag-mask ventilation and supraglottic airway use could help clinicians make better records of airway management.
- 10 October 2022
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 51 (1) , 43-50
What airway management information do anaesthetic charts prompt for? An audit of charts from 132 hospitals across Australia and New Zealand
Anaesthetists can make safer airway plans if they know which airway techniques worked previously and which ones did not. Anaesthetic charts do not always capture this information, however, and guidelines from the Australian and New Zealand College of Anaesthetists do not specify what details on airway management they should include. To assess how anaesthetic charts support airway documentation, we audited the airway management section of blank charts from 132 hospitals accredited for training by the Australian and New Zealand College of Anaesthetists. We evaluated charts for the presence of 17 clinically important data fields describing tracheal intubation, supraglottic airway use and bag-mask ventilation. Our audit revealed that data fields on anaesthetic charts focus more on tracheal intubation than bag-mask ventilation or supraglottic airway use. Nearly all charts (99%) had prompts for intubation and most had prompts for both operator technique and patient outcome. For supraglottic airway use, 95% of charts had at least one data field, but few had prompts for difficulty or outcome. For bag-mask ventilation, 58% of charts had a data field for difficulty but most of these were subjective; few (1.5%) included any outcome measures. Data fields describing bag-mask ventilation and supraglottic airway use were also inconsistent. In summary, data fields on Australian and New Zealand anaesthetic charts focus on tracheal intubation with consistent prompts for both operator method and outcome. The inclusion of fields for outcome and difficulty of bag-mask ventilation and supraglottic airway use could help clinicians make better records of airway management.